Growing pains
According to the Institute for Scientific Information, the average number of authors per paper has increased steadily, from 1.83 in 1955 to 3.9 today 1 . In Nature Genetics, the average number of authors per paper this year is 10, based on the 138 papers published so far, and not including those in this issue. Compared with 5 years ago, there has been a significant decrease in papers with 2 to 6 authors and an increase in ones with 12 to 16 authors.
The increase in authorship has been documented for many fields-the most frequently-cited example is high-energy physics, where the author list can take up an entire journal page. (In such papers, the authors are often listed in alphabetical order.) Interestingly, it has been accompanied by a proportional increase in the number of individuals mentioned in the Acknowledgments (also referred to as subauthorship) 1 .
It is easy to see why in genetics there is a trend toward more authors. Large geneexpression studies require collaboration among scientists with different expertise, and the same goes for genome-sequencing projects, which also require many hands and heads if they are to move quickly. In general, to be competitive, scientists need to collaborate.
But the trend has not been welcomed with open arms. Some of the biggest concerns that have been voiced in letters to the editor and other opinion pieces have to do with honorary authorship-the tendency of some senior scientists to take credit for a paper to which they did not contribute-and a diffused responsibility for the work as a whole. But the other major concern, and the focus of the most animated discussions, has to do with how long-author lists affect the way in which individual scientists are evaluated.
Scientists continue to be evaluated by granting agencies and faculty committees by the number of papers they have published, their positions in author lists (with the first and last authors being the coveted spots in biomedical research), and the impact factors of the journals in which they publish. Under this scheme, how would you judge a middle author in a genome-sequencing study with close to 100 names? Whereas the name in the list is hardly noticeable, the individual's contributions to the paper may have consumed a significant amount of his or her time. And how do you assess the contributions of two individuals who provide completely different sets of skills and expertise to a study? For example, is the contribution of the individual who isolates RNA and carries out the hybridization step of a microarray study more important than that of the bioinformatician who develops the algorhithms or software to analyze the data? The answer varies, depending on whom you ask.
volume 32 no. 1 september 2002
The order of authors in a paper depends on the field of science-biologists do it differently than do mathematicians or physicists-but within each field, the criteria for evaluating contributions vary greatly from lab to lab and, sometimes, country to country. If a study involves three different labs and scientists from disciplines outside biology, it becomes a challenge both to decide on the order of authors and to 'decode' what the order signifies. As a result, decisions on authorship often turn into involved and time-consuming negotiations among heads of labs, sometimes occurring long before any of the experiments have begun. (The use of asterisks to indicate equal contributions was introduced about ten years ago to deal with some of these issues, but it turns out that being the first 'asterisked' author is perceived as being better than the second one, and so on. Perhaps this is partly owing to the fact that asterisks are not indicated by Medline or PubMed or routinely used in citations in the published literature.)
The International Committee of Medical Journal Editors, also known as the Vancouver group, proposed in 1997 a set of guidelines for publishing biomedical research papers. Since then, over 500 journals have adopted the guidelines and agreed to the following authorship requirements:
Authorship credit should be based only on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting of the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Conditions 1, 2, and 3 must all be met 2 .
Nature Genetics has not subscribed to this definition of authorship. Whereas we agree that these criteria should apply to most studies, there are areas in genetics where all three would be difficult to fulfill. We hazard a guess that most authors on large genome-sequencing studies had little to do with the drafting or revising of the paper (criterion #2).
Another recommendation by the Vancouver group is that "authors should provide a description of what each contributed, and editors should publish that information." Last January, Nature Genetics adopted the policy that authors may outline their contributions in the acknowledgments section, but so far, few authors, if any, have done so 3 . Will listing the contributions reduce the incidence of honorific authorship? It seems unlikely. It might, however, make it easier for credit-granting bodies to ascertain the contributions that an individual has made to a paper in which s/he is not first or last author. There might also be some value in making the process of assigning authorship in a paper more transparent.
It's clear that, in light of the changing nature of collaboration in genetic and genomic studies, the almost-mathematical formulae used to rank scientists still used by some institutes need to be revised. As journal editors, we are deliberating our role in this transition. For the time being, we will strongly encourage our authors to list their contributions to published papers and invite discussion from funding agencies, administrators and scientists on these important issues. We welcome your comments.
